Metadata
Author: ParaCrawl Corpus
Data
English[en]
Eribulin has a proven overall survival benefit against dacarbazine and I hope that clinicians and patients will not have to wait much longer before being able to access this important new treatment," comments Professor Patrick Schöffski, Head of the Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
Spanish[es]
Eribulina presenta un beneficio probado en la supervivencia global en comparación con dacarbazina y espero que médicos y pacientes no tengan que esperar mucho más tiempo para poder acceder a este nuevo e importante tratamiento", comenta el catedrático Patrick Schöffski, director del Departamento de Oncología Médica General del Hospital Universtario de Leuven (Bélgica).